SETD2 anticorps
Aperçu rapide pour SETD2 anticorps (ABIN7384153)
Antigène
Voir toutes SETD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human SETD2 (NP_054878.5).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- SETD2 (SET Domain Containing 2 (SETD2))
-
Autre désignation
- SETD2
-
Sujet
- SETD2,HBP231,HIF-1,HIP-1,HSPC069,HYPB,KMT3A,LLS,SET2,p231HBP,Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II.
-
ID gène
- 29072
-
UniProt
- Q9BYW2
-
Pathways
- Tube Formation
Antigène
-